NCT04197336View on ClinicalTrials.gov

Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

December 14, 2023

Study Completion Date

December 14, 2023

Conditions
ObesityMorbid ObesityWeight Loss
Interventions
DEVICE

Bariatric Embolization of Arteries with imaging visible Embolics

bariatric embolization will be performed using tiny (100-200 μm), radiopaque (visible on X-ray) beads (referred to as BTG-001933) in order to suppress the body's signals for feeling hungry, which we predict will lead to weight loss.

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

Biocompatibles UK Ltd

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT04197336 - Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES) | Biotech Hunter | Biotech Hunter